Bevacizumab/cetuximabRash, hypertension, gastrointestinal bleed, and headache: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1585卷 / 1期

关键词：

D O I：

10.1007/s40278-016-13819-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：52 / 52

相关论文

共 50 条

[1] CetuximabRash: 2 case reports
[J]. Reactions Weekly, 2016, 1603 (1) : 64 - 64
[2] Bevacizumab/sunitinibPneumatosis intestinalis and gastrointestinal perforation: 6 case reports
[J]. Reactions Weekly, 2013, 1446 (1) : 8 - 8
[3] TenecteplaseHaemorrhagic transformation and gastrointestinal bleed: 2 case reports
[J]. Reactions Weekly, 2021, 1876 (1) : 307 - 307
[4] HeparinAlveolar haemorrhage and gastrointestinal bleed: 2 case reports
[J]. Reactions Weekly, 2018, 1694 (1) : 218 - 218
[5] Anticoagulants/antiplateletsMajor bleed: 6 case reports
[J]. Reactions Weekly, 2019, 1755 (1) : 29 - 29
[6] Bevacizumab/doxorubicinMyelosuppression and hypertension: 3 case reports
[J]. Reactions Weekly, 2022, 1888 (1) : 103 - 103
[7] Bevacizumab/ranibizumabOcular hypertension: 10 case reports
[J]. Reactions Weekly, 2021, 1877 (1) : 71 - 71
[8] AnticoagulantsWorsening of nose bleed and gastrointestinal bleeding: 26 case reports
[J]. Reactions Weekly, 2019, 1774 (1) : 32 - 32
[9] RivaroxabanPulmonary haemorrhage and upper gastrointestinal (GI) bleed : 2 case reports
[J]. Reactions Weekly, 2021, 1842 (1) : 328 - 328
[10] Bevacizumab/octreotideDiarrhoea, hypertension and epistaxis: 2 case reports
[J]. Reactions Weekly, 2020, 1792 (1) : 54 - 54

← 1 2 3 4 5 →